Chase Labs Nj Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHASE LABS NJ, and what generic and branded alternatives to CHASE LABS NJ drugs are available?
CHASE LABS NJ has two approved drugs.
Summary for Chase Labs Nj
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Chase Labs Nj
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chase Labs Nj | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 073421-001 | Jun 19, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Chase Labs Nj | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 072409-001 | Jul 4, 1990 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
